Adc Therapeutics SA (NYSE:ADCT) Down -15.08% Over The Past 30 Days: Any Troubles Ahead?
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 1.64 million shares changing hands with its beta currently measuring 1.92. Company’s recent per share price